Huadong Medicine Co., Ltd
000963
Rang in aandelen
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Aandeelprijs
$3.89
Marktkapitalisatie
$6.83B
Verandering (1 dag)
-2.22%
Verandering (1 jaar)
-30.58%
Land
CN
Handel Huadong Medicine Co., Ltd (000963)
Categorie
Healthcare
Aantal uitstaande aandelen voor Huadong Medicine Co., Ltd (000963)
Aantal uitstaande aandelen per June 2026: 1.75B
Volgens de laatste financiële rapporten en de aandelenkoers van Huadong Medicine Co., Ltd bedraagt het huidige aantal uitstaande aandelen 1.75B. Aan het einde van December 2024 had het bedrijf 1.75B uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Huadong Medicine Co., Ltd (000963) van 2001 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2026 (TTM) | 1.75B | 0.08% |
| 2025 | 1.75B | 0.02% |
| 2024 | 1.75B | 0.02% |
| 2023 | 1.75B | 0.10% |
| 2022 | 1.75B | 0.00% |
| 2021 | 1.75B | 0.00% |
| 2020 | 1.75B | 0.00% |
| 2019 | 1.75B | -0.44% |
| 2018 | 1.76B | 0.42% |
| 2017 | 1.75B | 0.83% |
| 2016 | 1.74B | 11.22% |
| 2015 | 1.56B | -0.30% |
| 2014 | 1.57B | -0.16% |
| 2013 | 1.57B | 0.10% |
| 2012 | 1.57B | 0.37% |
| 2011 | 1.56B | -0.27% |
| 2010 | 1.56B | -0.34% |
| 2009 | 1.57B | 0.88% |
| 2008 | 1.56B | -0.13% |
| 2007 | 1.56B | 12.06% |
| 2006 | 1.39B | -10.76% |
| 2005 | 1.56B | 0.00% |
| 2004 | 1.56B | 0.00% |
| 2003 | 1.56B | 0.00% |
| 2002 | 1.56B | 0.00% |
| 2001 | 1.56B | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 36.81% |
IN
|
